neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...
Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...
ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 28, 2005--At Pittcon 2005, Bruker Daltonics Inc., an operating company of Bruker BioSciences Corporation (NASDAQ: BRKR), today announces novel smartbeam(TM) laser ...
MALDI-TOF mass spectrometry is increasingly being applied as a clinical research tool in biomarker discovery, clinical proteomics, functional genomics, molecular imaging, and microorganism ...
At the 64th ASMS Conference, Bruker introduces rapifleX™, the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX ...
The firm bought selected assets in Glasgow, UK for the development, validation and commercialization of molecular assays for applications in microbiology. It includes lab infrastructure and IP in the ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure MALDI PharmaPulse is a complete mass ...
Bruker Daltonics of Billerica, Mass., has developed a new mass spectrometry system that the company describes as a "holistic solution" for clinical proteomics and biomarker discovery. The ClinProt™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results